Related Experiment Video
Updated: Jan 22, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Interrelations Between Arterial Stiffness, Target Organ Damage, and Cardiovascular Disease Outcomes
Ramachandran S Vasan1,2,3,4, Meghan I Short5, Teemu J Niiranen1,6,7
11 National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study Framingham MA.
Insights
Increased arterial stiffness is linked to target organ damage (TOD) and cardiovascular disease (CVD) events. Reducing arterial stiffness may lower the risk of TOD and CVD.
Area of Science:
- Cardiovascular Science
- Vascular Biology
- Clinical Medicine
Background:
- Increased arterial stiffness transmits excess pressure pulsatility, potentially causing end-organ damage (TOD).
- TOD, including albuminuria and left ventricular hypertrophy, elevates cardiovascular disease (CVD) risk.
Purpose of the Study:
- To investigate the association between arterial stiffness and TOD prevalence and incidence.
- To examine the relationship between TOD and incident CVD, considering arterial stiffness.
Main Methods:
- Utilized data from up to 6203 Framingham Study participants.
- Related arterial stiffness measures (e.g., pulse wave velocity) to TOD and incident CVD using multivariable Cox regression.
Main Results:
- Greater arterial stiffness correlated with higher TOD prevalence.
- Increased stiffness predicted incident albuminuria and left ventricular hypertrophy.
- TOD presence elevated incident CVD risk, partially mediated by arterial stiffness.
Conclusions:
- Elevated arterial stiffness is associated with TOD and may mediate the link between TOD and incident CVD.
- Mitigating arterial stiffness could reduce TOD and subsequent CVD burden.
Abstract:
Background Excess transmission of pressure pulsatility caused by increased arterial stiffness may incur microcirculatory damage in end organs (target organ damage [TOD] ) and, in turn, elevate risk for cardiovascular disease ( CVD ) events. Methods and Results We related arterial stiffness measures (carotid-femoral pulse wave velocity, mean arterial pressure, central pulse pressure) to the prevalence and incidence of TOD (defined as albuminuria and/or echocardiographic left ventricular hypertrophy) in up to 6203 Framingham Study participants (mean age 50±15 years, 54% women). We then related presence of TOD to incident CVD in multivariable Cox regression models without and with adjustment for arterial stiffness measures. Cross-sectionally, greater arterial stiffness was associated with a higher prevalence of TOD (adjusted odds ratios ranging from 1.23 to 1.54 per SD increment in arterial stiffness measure, P<0.01). Prospectively, increased carotid-femoral pulse wave velocity was associated with incident albuminuria (odds ratio per SD 1.28, 95% CI, 1.02-1.61; P<0.05), whereas higher mean arterial pressure and central pulse pressure were associated with incident left ventricular hypertrophy (odds ratio per SD 1.37 and 1.45, respectively; P<0.01). On follow-up, 297 of 5803 participants experienced a first CVD event. Presence of TOD was associated with a 33% greater hazard of incident CVD (95% CI , 0-77%; P<0.05), which was attenuated upon adjustment for baseline arterial stiffness measures by 5-21%. Conclusions Elevated arterial stiffness is associated with presence of TOD and may partially mediate the relations of TOD with incident CVD . Our observations in a large community-based sample suggest that mitigating arterial stiffness may lower the burden of TOD and, in turn, clinical CVD .
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction
Peripheral Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease IV: Nursing Management

